Poster Session

Poster Session III

Poster Session I

Poster Session II

Poster Session II

Poster Session I

Poster Session III

A Prospective Study of the Rabbit Syndrome

• Utpal Goswami
• BN Gangadhar
• R Sundararajan

Diet and Gender Moderate Clozapine-Related Weight Gain

• Carolyn Heimberg
• Fiona Gallacher
• Raquel Gur

Antipsychotic Dose Study in the Treatment of Schizophrenic Patients

• Chuong C Huang
• Rachel George

Spatial Memory Deficits In Parkinsonism

• Reese J Arcement
• David J Ingle
• Lucien J Cote

Quantitative Evaluation of the Cytoarchitecture of Areas 10 and 44 in Schizophrenia

• Vadim V Istomin
• Patrick R Hof

Predicting Patterns of Clozapine Response in a Group of Chronic State Hospital Schizophrenics

• J Lauriello
• DH Mathalon
• A Pfefferbaum

Paroxetine in Major Depression: a double blind comparison with fluvoxamine

• M Ansseau
• A Gabriels
• P Papart

Neuropeptidergic and Monoaminergic Function in Suicide Victims

• Belén Arranz
• Kaj Blennow
• Jan Marcusson

Study on Sleep Evaluation by Topography Mapping in Normal Volunteers and Aged Patients with Sleep and Cerebrovascular Disorders Following Administration of Zopiclone

• Hideyo Katsunuma
• Hiroshi Matsuda
• Tsuguharu Hosoya

Alpha-Tocopherol Succinate, But Not Alpha-Tocopherol Or Other Vitamin E Analogs Stimulates Prolactin And Growth Hormone Release From Rat Anterior Pituitary Cells in vitro

• M Badamchian
• B Spangelo
• AL Goldstein

Utilization Of Bayes' Theorem To Estimate The Predictive Value Of The A1 Allele Of The D2 Dopamine Receptor Gene In Compulsive Disease

• K Blum
• PJ Sheridan
• E Braverman

Predictors of Tardive Dyskinesia in First Episode Schizophrenia

• Miranda Chakos
• Jose Alvir
• Jeffrey Lieberman

Receptor Binding Autoradiography With Pramipexole, A Clinically Useful D3-Preferring Dopamine Agonist

• M Camacho-Ochoa
• DL Evans
• MF Piercey

High Dosages Of Neuroleptics --A survey in a long-term hospital

• Jose de Leon
• Carla Canuso
• George M Simpson